This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer Logo
BAYERPROYour Resource Portal
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Women's Health
  • Jaydess® ▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Ophthalmology
  • Eylea® (aflibercept) 8mg
Products
  • Cardiology
  • Oncology
  • Ophthalmology
  • Women's Health
  • Cardiology Resources
  • Oncology Resources
  • Ophthalmology Resources
  • Women's Health Resources
  • Bayer Events & On Demand Webinars
  • Cardiology Events & On Demand Webinar
  • Oncology Events & On Demand Webinars
  • Ophthalmology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Cardiology Learning Zone
  • Oncology Learning Zone
  • Ophthalmology Learning Zone
  • Women's Health Learning Zone
  • Cardiology Podcasts
  • Oncology Podcasts
  • Ophthalmology Podcasts
closesearch
Recent Searches
    You are now leaving BayerPRO

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    BayerPRO IRE Above Brand Header

    Products

    View more
    About Beyonttra®▼ (acoramidis)
    Learn more about Beyonttra® (acoramidis).
    Beyonttra Prescribing Information
    PP-BEY-IE-0031-1, November 2025
    About NUBEQA® (darolutamide)
    Access key information about NUBEQA® (darolutamide).
    NUBEQA Prescribing Information
    PP-NUB-IE-0264-1, December 2025
    Jaydess®▼(13.5mg Levonorgestrel)
    Discover information about Jaydess's intended use.
    Jaydess® Prescribing Information
    PP-JAY-IE-0056-1, January 2026
    Qlaira® (Estradiol valerate/dienogest)
    Discover more about intended use of Qlaira®
    Qlaira® Prescribing Information
    PP-QLA-IE-0001-1, January 2026

    Latest Resources

    View more
    Bayer in Women's Health
    Discover our heritage in making a positive difference to Women and their Health Professionals.
    PP-PF-WHC-IE-0938-1, February 2026
    Counselling Patients
    Simple steps on counselling women about intrauterine contraception (IUC) to support your practice.
    PP-PF-WHC-IE-0936-1, February 2026

    Webinars & On Demand Content

    View more
    Bayer's 18th Annual Lecture in Women's Health (2019)
    Urogynaecology in general practice – Pelvic organ collapse and other challenges
    PP-PF-WHC-IE-0911-1, February 2026
    Troubleshooting the IUS​
    Webinar series with modules on insertion, pain, expulsion, positioning of IUS.
    PP-PF-WHC-IE-0920-1, February 2026
    Bayer's Spotlight on Contraception Webinar Series​
    Three sessions covering counselling tips about contraceptive options.
    PP-PF-WHC-IE-0919-1, February 2026
    EYLEA® (aflibercept) 8mg | Events & Webinars
    Discover Events & On Demand Webinars below that you can access to learn more about EYLEA 8mg.
    EYLEA Prescribing Information
    PP-EYL_8mg-IE-0161-1, January 2026

    Learning Zone

    View more
    IUD choice and advice with Dr. Deirdre Lundy
    GP Buddy Tutorials
    PP-PF-WHC-IE-0932-1, February 2026
    GP Buddy Tutorials
    A series of 3 video tutorials covering: IUD insertion | IUD Choice and Advice | Menopause
    PP-PF-WHC-IE-0930-1, February 2026
    Menopause with Dr. Rachel Mackey
    GP Buddy Tutorials
    PP-PF-WHC-IE-0931-1, February 2026
    IUD insertion with Dr. Deirdre Lundy
    GP Buddy Tutorials
    PP-PF-WHC-IE-0933-1, February 2026

    Create an account

    Personalise your experience, stay up to date with additional resources and keep up to date via electronic communications from Bayer PLC.

    Don’t have an account?